Page 6 - Topical Solution News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA Flags 13 More Sanitizers, Issues One Warning for Methanol Content May 21, 2021 Contact Author Rachel Grabenhofer Close Sponsored Methanol content, or associations therewith, are cited as the reasons for 12 of the 13 latest additions by FDA to its 'do not use' hand sanitizer list. This brings the total number of entries to 249 as of May 20, 2021. In addition, the administration issued one warning letter for a hand sanitizer disinfectant gel containing ~65% methanol that was detained at the U.S. border. Products added to the FDA's list of product violations include: Durisan Anti...

April showers brings May fur friends | Adopt a pet, May 1-2 Posted Apr 30, 2021 Facebook Share STATEN ISLAND, N.Y. — ‘Tis the season for ticks. Check your fur babies as often as possible or at least at the end of every day. It’s not extra work if it keeps our loved ones safe from harm. It only takes a minute to look them over, but it’s worth the time. Where do you look when checking for ticks? The diagram below should help. If you give them a good rub down after being outside, you will be able to feel them.

Alembic Pharmaceuticals (Alembic) today announced that its joint venture Aleor Dermaceuticals (Aleor) has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Efinaconazole Topical Solution, 10%. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Jublia Topical Solution, 10%, of Bausch Health Americas, Inc. (Bausch). Efinaconazole Topical Solution, 10% is indicated for the topical treatment of onychomycosis of the toenail(s) due to Trichophyton rubrum and Trichophyton mentagrop...

Aleor Dermaceuticals receives USFDA Tentative Approval for Efinaconazole Topical Solution, 10% Posted On: 2021-04-07 22:47:15 (Time Zone: Arizona, USA) Alembic Pharmaceuticals Limited (Alembic) today announced that its joint venture Aleor Dermaceuticals Limited (Aleor) has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Efinaconazole Topical Solution, 10%. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Jublia Topical Solution, 10%, of Bausch Health Americas, Inc. (B...

Easy-Application Tube for Veterinary Products Wins Gold Antiparasitic Revolt™ Topical Solution from Aurora Pharmaceuticals is housed in a customized version of Neopac’s Twist’n’use™ tube. Mar 8th, 2021 The Tube Council awarded Hoffmann Neopac a gold award in the “Best Pharmaceutical Tube” category for its convenient, high-barrier single-use tube with a simple, no-mess applicator developed for Aurora Pharmaceuticals, Inc., a US-based manufacturer and distributer of animal health medicines. Aurora chose a customized version of Neopac’s Twist’n’use™ tube for its prescri...